InvestorsHub Logo
Followers 3060
Posts 148038
Boards Moderated 21
Alias Born 03/01/2004

Re: None

Thursday, 10/31/2019 1:33:33 AM

Thursday, October 31, 2019 1:33:33 AM

Post# of 26145
Important note about FAGI >>>there was a pilot study done before about Ozone Therapy for Tumor Oxygenation

This prospective study was designed to assess the effect of ozone therapy on tumor oxygenation







https://www.ncbi.nlm.nih.gov/pmc/articles/PMC442111/

at the end of the study the conclusion came that way :

In conclusion, many aspects regarding the bio-medical application of ozone therapy remain unexplored. In the present prospective study, the effect of ozone therapy on human tumor pO2 has been measured using the polarographic probe technique, and the results indicate that ozone therapy could increase oxygenation in the most hypoxic tumors. This suggests the potential use of this therapy as adjuvant in chemo-radiotherapy schedules, and would warrant further investigation.

and NOW


the Nobel Prize was awarded on Oct 7 ,2019 to 3 scientists


The Nobel Prize

@NobelPrize

BREAKING NEWS:
The 2019 #NobelPrize in Physiology or Medicine has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.”



Why is the work important?

The discoveries reveal the cellular mechanisms that control such things as adaptation to high altitudes and how cancer cells manage to hijack oxygen. Randall Johnson, a member of the Nobel Assembly, described the work as a “textbook discovery” and said it would be something students would start learning at the most basic levels of biology education.

“This is a basic aspect of how a cell works, and I think from that standpoint alone it’s a very exciting thing,” Mr. Johnson said.

The research also has implications for treating various diseases in which oxygen is in short supply — including anemia, heart attacks and strokes — as well as for treatment of cancers that are fed by and seek out oxygen.



https://www.nytimes.com/2019/10/07/health/nobel-prize-medicine.html



and here comes FAGI NEWS >>FAGI Files EBO2 Patent

here are your key words from the PR that makes you understand why FAGI is going to run very high >>>>



Paul Brian Volpp, CEO and President of Full Alliance Group, commented, "Having now filed the required paperwork to the patent office will open up significantly more avenues for Full Alliance to begin large-scale marketing of extracorporeal ozone oxygenation."


and


the company plans to begin multiple clinical trials throughout the country which would begin the preliminary process of obtaining FDA approval. Discussions have already begun to initiate trials in San Diego, California and Lynchburg, Virginia.



and


"We are also quite excited to learn that the recent Nobel Prize in Medicine was awarded to American researchers who showed the critical importance of oxygen modulation by cells in cancer as well as cardiac and other chronic diseases," continued Dr. Volpp. "Our medical advisory board plans to redouble its efforts now to expand the use of EBO2 in a variety of illnesses. With a recent influx in investor capital we feel that we will make significant progress in Q4 of 2019, and in the process build shareholder value.



FAGI plan is going to expand the use of EBO2 for Cancer treatment and a variety of illnesses!!


Discussions have already begun to initiate trials in San Diego, California and Lynchburg, Virginia.


from the last PR >>>

With preorders for the EBO2 unit having already begun in San Diego, Los Angeles, the Bay Area and Cincinnati, Dr. Cook's facility in California will become the national training site for all physicians and practitioners who lease the machine.



"Dr. Cook with continue to provide a critical role as we begin the large-scale roll out of the EBO2 units. With the interest we have seen in this preorder phase, providing comprehensive training to practitioners and staff will require a convenient site and excellent mentors. Dr. Cook and his facility provides both of these things," concluded Dr. Volpp.